Sonoma Pharmaceuticals Inc.
SNOA | NASDAQ
$1.25
-$0.03 (-2.34%)
At close: Sep 21, 2026, 4:00 PM ET
$1.27
+$0.02 (+1.49%)
Pre-market:
Sep 22, 2026, 7:00 AM ET
Market Data
Market Cap $2.16M
Enterprise Value $-2.49M
Beta 1.31
Average Volume 148.61K
Shares Outstanding (Diluted) 3.85M
Shares Change YoY 134.37%
Institutional Ownership 4.01%
Exchange NASDAQ
ISIN US83558L3033
Price Performance
Price Change 1M -5.3%
Price Change 3M 9.7%
Price Change 6M -45.2%
Price Change YTD -65.7%
Price Change 1Y -70.0%
Price Change 3Y -92.0%
Price Change 5Y -98.8%
1M CAGR (ann.) 2.4%
1Y CAGR (ann.) -68.6%
5Y CAGR (ann.) -59.1%
All-Time CAGR -41.5%
Valuation
PE Ratio -1.02
Forward PE N/A
PEG Ratio -0.01
Forward PEG 0.01
PS Ratio 0.10
Forward PS 0.10
PB Ratio 0.32
P/FCF Ratio -0.98
P/Adj. FCF Ratio -0.87
P/OCF Ratio -2.36
EV/Sales -0.11
EV/EBIT 1.47
EV/EBITDA 1.57
EV/FCF 1.16
Earnings Yield -97.6%
FCF Yield -102.2%
Adj. FCF Yield -114.4%
Financial Health
Net Cash $4.6M
Total Debt $739K
Cash & Short-Term Investments $5.34M
Total Assets $18.11M
Current Ratio 2.99
Quick Ratio 2.29
Debt / Equity Ratio 0.11
Debt / EBITDA -0.46
Debt / FCF -0.34
OCF / Debt -2.74
Interest Coverage 0.00
Altman Z-Score -13.83
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 38.9%
Operating Profit Margin -6.4%
EBITDA Margin -7.3%
Net Profit Margin -10.3%
FCF Margin -9.8%
Adj. FCF Margin -11.0%
SBC / Revenue 1.2%
SBC Impact (per share) -11.9%
Returns
Return on Assets -12.5%
Return on Equity -53.6%
Return on Invested Capital -9.8%
Return on Capital Employed -11.1%
Return on Tangible Assets -12.5%
Historical Growth (CAGR)
Revenue CAGR 3Y 19.9%
Revenue CAGR 5Y 5.8%
Revenue CAGR 10Y 5.6%
EPS CAGR 3Y 81.1%
EPS CAGR 5Y 51.1%
EPS CAGR 10Y 38.7%
FCF CAGR 3Y -24.1%
FCF CAGR 5Y 33.2%
FCF CAGR 10Y 20.5%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Cash Flow
Operating Cash Flow $-2.03M
Free Cash Flow $-2.15M
Adj. Free Cash Flow $-2.41M
FCF Per Share -$0.56
OCF Per Share -$0.53
OCF/S Ratio -9.2%
Income Statement
Revenue $21.92M
Gross Profit $8.53M
Operating Income $-1.41M
EBITDA $-1.59M
Net Income $-2.26M
EPS (Diluted) -$1.22
Revenue / Employee $2.19M
Profit / Employee $-226.4K
Employees 10
Add to Watchlist
Select watchlists to add or remove SNOA